A father from Seattle, Washington was shocked and overwhelmed after strangers came together to raise more than $150k for him ...

As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.

OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it received a Notice of ...

Despite new paradigm-shifting treatments, lung cancer remains a deadly ... as the percentage of patients whose cancer cells die by more than 90% in the resected specimen, however the definition ...

A noteworthy case study. What caused a 43-year-old woman to develop lesions all over her body that were not only extremely ...

Lobectomy has advantages over other surgical options for lung cancer. Among them: fewer serious complications. For example, whereas a lobectomy removes one lobe of the lungs, a sleeve resection ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

Human health is strongly intertwined with the health of the microbiome. A large number of studies have shown that the human ...

However, the nation has now been embroiled in this "war" for over 50 years, and we are nowhere closer to victory, argues ...

Feb. 19, 2025 — Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could ...

The following is a summary of "Prophylactic cranial irradiation improved the prognosis in pT1-2N0M0 small cell lung cancers ...